510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K926559Substantially Equivalent

Proact Biopsy Needle Enchancements

Proact, Ltd., State College PA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K926559 is the FDA 510(k) clearance record for PROACT BIOPSY NEEDLE ENCHANCEMENTS, a class II device, cleared for Proact, Ltd. on under FDA product code FCG (Biopsy Needle). FDA records list 7 510(k) clearances for Proact, Ltd., from to . As of , FDA records show no recalls naming K926559.

Clearance record

Decision date
Received
(81 days to decision)
Product code
FCG Biopsy Needle
Regulation
21 CFR 876.1075
Device class
Class II
Review panel
Gastroenterology, Urology
Applicant
Proact, Ltd. Calder Sq. Box 11029, State College PA
510(k) summary
Statement
Third party review
No

Clearances, product code FCG

Trailing 12 months

FDA records hold no clearances under product code FCG in the trailing twelve months.

FDA records show no clearances under product code FCG in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code FCG, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260